Health ❯ Healthcare ❯ Patient Care

Chronic Illness Management

Support Systems Quality of Life Alzheimer's Disease Treatment Diabetes Care Dementia Care Alzheimer's Disease HIV Management Heart Disease Management Alzheimer's Treatment Options Kidney Disease

3 ARTICLES

last wk.

FDA Approves Lisraya for Adult Dermatomyositis

The decision clears a new targeted JAK/TYK2 oral pill after a 52-week trial showed measurable clinical benefit and less steroid use for some patients.

4 ARTICLES

2w ago

Novartis Moves to File Oral MS Drug After Phase‑3 Win as Separate CAR‑T Trials Are Paused

3 ARTICLES

2w ago

FDA Approves Bixlenvo, a Once‑Daily Single‑Pill HIV Regimen

8 ARTICLES

3w ago

NICE Recommends Once-Weekly Insulin Onswik for Adults With Type 2 Diabetes

6 ARTICLES

3w ago

FDA Grants Accelerated Approval to Genglycos for Glycogen Storage Disease Type Ia

24 ARTICLES

last mo.

UNAIDS Warns Funding Cuts Threaten HIV Gains as New Preventive Drugs and Two Remissions Offer Hope

3 ARTICLES

2mo ago

Hospital 12 de Octubre Performs First Simultaneous Intestine-and-Pancreas Block Transplant in Spain

3 ARTICLES

3mo ago

Defective 5′‑Leader HIV Genomes Drive Most Persistent Viremia on ART

6 ARTICLES

3mo ago

Indio Solari Dies at 77 After Long Battle With Parkinson

9 ARTICLES

3mo ago

World Multiple Sclerosis Day Puts Spotlight on Treatment Shortfalls in Latin America

3 ARTICLES

3mo ago

ViCentra Starts Commercial Production of Kaleido Consumables

4 ARTICLES

3mo ago

Brazil Approves 24‑Hour Subcutaneous Levodopa Therapy for Advanced Parkinson

5 ARTICLES

4mo ago

Norway’s Crown Princess Mette-Marit Uses Oxygen at Constitution Day Appearance

10 ARTICLES

4mo ago

Spain Publishes Drug Copay Overhaul With New Caps and Wider Pensioner Exemptions

4 ARTICLES

4mo ago

FDA Clears Once-Weekly Saphnelo Pen for Self-Injection in Lupus

3 ARTICLES

4mo ago

Chronic Illness Management

FDA Approves Lisraya for Adult Dermatomyositis

Novartis Moves to File Oral MS Drug After Phase‑3 Win as Separate CAR‑T Trials Are Paused

FDA Approves Bixlenvo, a Once‑Daily Single‑Pill HIV Regimen

NICE Recommends Once-Weekly Insulin Onswik for Adults With Type 2 Diabetes

FDA Grants Accelerated Approval to Genglycos for Glycogen Storage Disease Type Ia

UNAIDS Warns Funding Cuts Threaten HIV Gains as New Preventive Drugs and Two Remissions Offer Hope

Donanemab Slows Alzheimer's Decline, New AAIC Data Show

FDA Grants Accelerated Approval to Trutakna for IgA Nephropathy

FDA Grants Priority Review to Roche’s Enspryng for Thyroid Eye Disease

NICE Approves Teplizumab for Early Type 1 Diabetes on the NHS

Never miss stories about

Chronic Illness Management

Hospital 12 de Octubre Performs First Simultaneous Intestine-and-Pancreas Block Transplant in Spain

Defective 5′‑Leader HIV Genomes Drive Most Persistent Viremia on ART

Indio Solari Dies at 77 After Long Battle With Parkinson

World Multiple Sclerosis Day Puts Spotlight on Treatment Shortfalls in Latin America

ViCentra Starts Commercial Production of Kaleido Consumables

Brazil Approves 24‑Hour Subcutaneous Levodopa Therapy for Advanced Parkinson

Norway’s Crown Princess Mette-Marit Uses Oxygen at Constitution Day Appearance

Spain Publishes Drug Copay Overhaul With New Caps and Wider Pensioner Exemptions

FDA Clears Once-Weekly Saphnelo Pen for Self-Injection in Lupus

AstraZeneca’s Tozorakimab Hits Phase III Goal in COPD, Marking Third Positive Pivotal Trial

Never miss stories about

Chronic Illness Management